Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.31 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain excitatory neurons; strongest in vascular smooth muscle cells | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 3 Parkinson's papers of 308 | 0.82 |
| pathways Reactome | 3 pathways; mostly growth signalling | 0.60 |
No case: the score is under the bar. Receipt 1161
Sealed predictions
- SLIT3 in dopamine neurons, braak-0.29 (p 0.456) → +0.03 (p 0.946)receipt 1169
Swarm cases
receipt 1169: SLIT3 in dopamine neurons, braak
- power
- full sample -0.17 (p 0.498, n 18), 95% CI -0.59 to +0.32. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.16 (p 0.538, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.37 (p 0.132, n 18). could be the mix.
- skeptic
- leave-one-out range -0.29 to -0.06, sign flips 0; without severely affected donors -0.17 (p 0.498, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLIT3 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts